SBC Medical Group Holdings (SBC) executive compensation, 2026 proxy

Yoshiyuki Aikawa, Chief Executive Officer (principal executive officer), was paid $12M in 2025, down 17% from $14.5M the year before.

Filed
May 28, 2026
Annual meeting
July 9, 2026
Pay year
2025
Named executives
3
CEO total pay
$12M-17% vs prior year
Yoshida total compensation
$416,072Includes $99,338 discretionary bonus
Yamazaki total compensation
$359,174Includes $83,391 discretionary bonus
Yoshida 2024 total
$304,404
CEO 2024 total
$14,506,032

How Aikawa was paid

$12M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary100%

Named executive officers

ExecutiveTotal
Yoshiyuki AikawaChief Executive Officer (principal executive officer)$12,000,000
Yuya YoshidaChief Financial Officer and Chief Operating Officer$416,072
Miki (Shimizu) YamazakiChief Strategy Officer$359,174

What changed and why

  • $12M$12,000,000 was CEO Yoshiyuki Aikawa’s 2025 salary, compared with $14,506,032 total compensation in 2024.
  • $99,338$99,338 discretionary bonus was paid to CFO and COO Yuya Yoshida for 2025.
  • $83,391$83,391 discretionary bonus was paid to Chief Strategy Officer Miki Yamazaki for 2025.
  • No equity grants were made to any named executive officer for 2025.
  • Cash compensation currently comprises the entire executive compensation program.
  • Future long-term incentive compensation is expected to use equity awards.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.